Nectar Lifesciences Ltd.
NECLIFE Share PricePharmaceuticals & Drugs
₹14.16
-0.4 (-2.8%)
As on September 8, 2025
Exchange Scrips: BSE532649NSENECLIFEISININE023H01027
Market Cap ₹ 316 Cr
P/E Ratio 63.58
Dividend Yield N/A
Performance
Market performance
Open14.79
High14.79
Volumes2,76,519
Prev14.16
Low14.1
As on2025-09-08
Historical performance
1 Year High56.5
3 Year High56.5
5 Year High56.5
1 Year Low13.05
3 Year Low13.05
5 Year Low13.05
Fundamentals
Company Valuation
Market Cap (₹Cr)
316
Face Value (₹)
1
P/E Ratio
63.58
Dividend Yield
N/A
Investment Returns
1 Year
-72.6%
3 Years
-38.8%
5 Years
-29.6%
10 Years
-60.1%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 14.48 | Bearish |
| 10-DMA | 14.61 | Bearish |
| 20-DMA | 14.82 | Bearish |
| 50-DMA | 16.95 | Bearish |
| 100-DMA | 20.11 | Bearish |
| 200-DMA | 26.4 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 3 | 3 | 3 | 2 | 2 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 3 | 3 | 3 | 2 | 2 |
| Public Investors | 71974 | 69238 | 69479 | 66738 | 58227 |
| Government | 1 | 1 | 1 | 1 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 63.58.
- 3Y Stock Price CAGR of the stock is -16.3.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹1759 Million.
- The company generated revenue of ₹16841 Million in the previous financial year.
Nectar Lifesciences Ltd.
14.16-0.4 (-2.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 275004.9
No. of Shares: 19421 (Approx)
Performance:-72.5%
P/L: ₹-724995.1
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent